Causes of CLD
Reading File
Finding Sources
Searching PubMed
"chronic liver disease" etiology causes
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Here is a comprehensive, textbook-grounded breakdown of the causes of Chronic Liver Disease (CLD):
Causes of Chronic Liver Disease (CLD)
The following categories should be systematically considered when evaluating CLD. A systematic approach - history, examination, blood/urine tests, imaging, and biopsy - is often needed because the cause is not always immediately obvious.
(Tietz Textbook of Laboratory Medicine, 7th Ed.)
1. Toxic / Substance-Related
| Cause | Notes |
|---|---|
| Alcohol (Alcohol-related liver disease, ArLD) | #1 cause in Western countries; accounts for ~20% of transplant listings as primary diagnosis, and up to 40-50% as a secondary diagnosis. Alcoholic cirrhosis surged to 37% of transplant listings in 2021 during/after COVID-19. |
| Drugs | Hepatotoxic medications - antibiotics, NSAIDs, anticonvulsants, statins, isoniazid, antidepressants, herbal supplements |
2. Viral
| Cause | Notes |
|---|---|
| Hepatitis B (HBV) | Major global cause; treated with nucleoside/nucleotide HBV DNA polymerase inhibitors or pegylated interferon-alpha |
| Hepatitis C (HCV) | Historically caused up to 60% of transplants at some centers; now dramatically reduced due to direct-acting antivirals with ~100% cure rates (only 7% of listings in 2021) |
| Hepatitis D | Co-infection or superinfection with HBV only |
3. Metabolic / Genetic Diseases
| Cause | Notes |
|---|---|
| Non-alcoholic fatty liver disease / NASH (MASLD/MASH) | Rapidly rising - now the 2nd leading indication for liver transplantation in the US (19% in 2021). Affects 2-5% of Americans with steatohepatitis; 10-20% have NAFLD alone. Strongly linked to obesity, insulin resistance, and metabolic syndrome. |
| Hemochromatosis | Iron overload; commonest form is HFE-related (autosomal recessive). C282Y mutation (homozygous) accounts for 85-90% of cases in northern Europeans. |
| Wilson's disease | Copper accumulation; treated with penicillamine, zinc, or trientine |
| Alpha-1 antitrypsin (AAT) deficiency | Protease inhibitor accumulation in hepatocytes |
| Porphyria cutanea tarda | Associated with iron overload and hepatic porphyrin accumulation |
4. Immune-Mediated
| Cause | Notes |
|---|---|
| Autoimmune hepatitis (AIH) | Interface hepatitis; responds to immunosuppression |
| Primary Biliary Cholangitis (PBC) | Formerly "primary biliary cirrhosis"; presents with malaise, lethargy, pruritus, abnormal LFTs |
| Primary Sclerosing Cholangitis (PSC) | Chronic cholestatic disease; diffuse fibrosis/stricturing of intra- and extrahepatic bile ducts; associated with ulcerative colitis; mainly affects young men. Strong predisposition to cholangiocarcinoma. No specific treatment - most require liver transplantation. |
5. Vascular
| Cause | Notes |
|---|---|
| Budd-Chiari syndrome | Hepatic vein outflow obstruction; presents with ascites, pain, abdominal distension |
| Post-portacaval shunting | Secondary hepatic injury after surgical shunts |
| Right heart failure / congestive hepatopathy | Chronic venous congestion ("cardiac cirrhosis") |
6. Infiltrative / Biliary
| Cause | Notes |
|---|---|
| Caroli's disease | Congenital biliary dilatation; presents with abdominal pain, sepsis, biliary obstruction |
| Polycystic liver disease | Associated with hepatomegaly and pain |
| Simple liver cysts | Usually incidental |
| Secondary biliary cirrhosis | Chronic biliary obstruction from stones, strictures, or tumors |
7. Cryptogenic
- ~10-15% of CLD cases have no identifiable cause after full workup, termed "cryptogenic." Many cases formerly classified as cryptogenic are now recognized as burnt-out NASH. (Goldman-Cecil Medicine)
8. Miscellaneous / Rare
- Dysmetabolic iron overload syndrome
- Aceruloplasminemia (iron metabolism disorder)
- Congenital atransferrinemia
- Neonatal/congenital alloimmune hepatitis
- Sarcoidosis, amyloidosis (hepatic infiltration)
Key Points from Current Literature
- MASLD (formerly NAFLD/NASH) is the fastest-growing cause of CLD globally, driven by the obesity epidemic - a 2026 JAMA review (PMID: 41212550) highlights its increasing burden.
- Alcohol remains the dominant cause overall, with a pandemic-related surge noted in transplant data.
- Hepatitis C has been largely eliminated as a major cause due to curative antiviral therapy.
Sources: Sleisenger & Fordtran's GI and Liver Disease; Harrison's Principles of Internal Medicine 22E; Bailey and Love's Surgery 28E; Tietz Textbook of Laboratory Medicine 7E; Current Surgical Therapy 14E.
This is a shared conversation. Sign in to Orris to start your own chat.